Join Medicilon at the AACR Annual Meeting 2024
The AACR Annual Meeting is a premier gathering for cancer researchers, where groundbreaking advances in cancer science and medicine are shared. Medicilon is thrilled to exhibit at this crucial event.
Medicilon: Your One-Stop R&D Partner
As a leading integrated CRO, Medicilon offers comprehensive drug discovery services for pharmaceutical and research institutions worldwide. By the end of 2023, we've served over 2,000 clients globally, with 300+ INDs approved in China and 80+ overseas.
Unparalleled Expertise in Immuno-Oncology
Medicilon boasts over 370 tumor evaluation models. We're at the forefront of immuno-oncology research, actively supporting the evaluation and development of innovative therapies like CAR-T, TCR-T, and more.
Date: April 5-10, 2024
Location: San Diego Convention Center, San Diego, California
Medicilon Booth #4021
Meet Dr. Qingcong Lin, President of Medicilon USA Corp.
Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Visit him at Medicilon booth #4021 to discuss your research needs.
Meet Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon
With nearly three decades in pharmaceutical R&D management, Dr. Li has deep expertise in drug development, including CMC services and CRO/CDMO management, accumulating rich experience and profound knowledge.